Anzeige
Mehr »
Login
Donnerstag, 25.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
158 Leser
Artikel bewerten:
(0)

InvestmentPitch: Vodis Pharmaceuticals (CSE:VP) Lists on the Canadian Securities Exchange - Video News Alert on Investmentpitch.com

Vancouver, BC, July 30, 2014 - Vodis Pharmaceuticals (CSE:VP)) is one of the latest new listing on the Canadian Securities Exchange, having previously traded as Southbridge Resources under the symbol SOU.

InvestmentPitch.com has produced a "video news alert (http://www.investmentpitch.com/video/0_sjv0vfu9/Vodis-Pharmaceuticals-CSE-VP-New-Listing)" which provides a brief overview of the company.  If this link is not enabled, please visit www.InvestmentPitch.com (http://www.InvestmentPitch.com) and enter "Vodis" in the search box.

Vodis Pharmaceuticals, through the purchase of Vodis Innovative Pharmaceuticals, which will become a wholly owned subsidiary, and another private BC numbered company, which was a marijuana producer under the previous Health Canada regulations, has made an application to Health Canada to become a Licensed Producer under the new Marijuana for Medical Purposes Regulation.

Vodis filed its MMPR in August of 2013 and in January of 2014 received a 'ready to build' letter from Health Canada, and is currently awaiting Health Canada's final inspection.

The company had been operating under the previous MMAR regulations at its 6-room, 12,000 square foot production facility. This was recently upgraded to eight rooms, consisting of between 40 and 50 lights per room.

To acquire the License and the Assets, Southbridge issued 36 million shares in addition to another 1,440,000 shares as a finder's fee. Subject to the issuance of the new License, for which there is no assurance, the company will pay $500,000 to the vendor.

Upon issuance of the license, the company will begin marketing and sales of its current product line, which consists of a number of types of marijuana and a number of packaging options, through its website. The company expects that it will take approximately 4 months to reach acceptable levels of production, sales and marketing, and has estimated production when fully operational under the MMPR license to be between 150 - 200 pounds of cannabis per month.

The shares are trading at $0.40 and with 48.6 million shares currently outstanding, the company is capitalized at $19.4 million. For more information, please visit the company's website www.vodis.ca (http://www.vodis.ca) or for investor inquires contact Otto Folprecht at 1-866-210-1420 or email otto@vodis.ca (mailto:otto@vodis.ca)
.
About InvestmentPitch

InvestmentPitch.com, a multimedia company that provides a combined solution for creating and hosting financial video content, and distributing it across multiple platforms to investors and financial professionals, specializes in producing short three minute videos based on significant news releases and research reports. Please visit InvestmentPitch.com and browse the extensive library of investment videos.

CONTACT:
InvestmentPitch.com
Barry Morgan, CFO
bmorgan@investmentpitch.com (mailto:bmorgan@investmentpitch.com)





This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: InvestmentPitch via Globenewswire

HUG#1844250
Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2014 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.